Daan Van Brusselen, Katrien De Troeyer, Eva Ter Haar, Ann Vander Auwera, Katleen Poschet, Sascha Van Nuijs, An Bael, Kim Stobbelaar, Stijn Verhulst, Bruno Van Herendael, Philippe Willems, Melissa Vermeulen, Jeroen De Man, Nathalie Bossuyt, Koen Vanden Driessche

PMID: 33517482 PMCID: PMC7847293 DOI: 10.1007/s00431-021-03968-6

Abstract

Stay-at-home orders, physical distancing, face masks and other non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. Bronchiolitis is a clinically diagnosed viral infection of the lower respiratory tract, and causes a yearly seasonal wave of admissions in paediatric wards worldwide. We counted 92,5% less bronchiolitis hospitalisations in Antwerp before the expected end of the peak this year (of which only 1 RSV positive), as compared to the last 3 years. Furthermore, there was a >99% reduction in the number of registered RSV cases in Belgium.Conslusion: The 2020 winter bronchiolitis peak is hitherto nonexistent, but we fear a ‘delayed’ spring/summer bronchiolitis peak when most NPIs will be relaxed and pre-pandemic life restarts. What is known? • Bronchiolitis causes a yearly seasonal wave of admissions in paediatric departments worldwide. • Non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. What is new? • The 2020 winter bronchiolitis peak is hitherto nonexistent. • A ‘delayed’ spring or summer bronchiolitis peak could happen when most NPIs will be relaxed and pre-pandemic life restarts.

Keywords: Bronchiolitis; COVID-19; Lockdown; Non-pharmaceutical interventions (NPIs); Paediatric Infections; RSV.

More on: I-PREVENT

More on: Bronchiolitis | RSV